The Patent Finder

Centrexion Therapeutics Corporation

35 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

6
Ending by 2030
Aug 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 30, 2026
    The maintenance fee for Process and Intermediates for the Production of CCR2 Antagonists (US 9,067,951) comes due Dec 30, 2026. Unpaid by Jun 30, 2027, it lapses early.
  • 2 fees due Feb 15 to 22, 2027 · next Feb 15
  • 1 fee due May 21, 2027
    The maintenance fee for Capsaicinoid Prodrug Compounds and Their Use in Treating Medical Conditions (US 11,820,727) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
  • 1 fee due Jun 3, 2027
    The maintenance fee for Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof (US 10,493,047) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
  • 1 fee due Jul 16, 2027
    The maintenance fee for Compositions and Methods for Intrathecal Administration of Mcoppb for Pain Relief (US 11,872,219) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
  • 2 fees due Aug 25, 2027

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,119,694High Concentration Local Anesthetic Formulations
In force
 · Medium confidence
In forceMedium confidence
US 11,517,546High Concentration Local Anesthetic Formulations
In force
 · Medium confidence
In forceMedium confidence
US 9,067,951Process and Intermediates for the Production of CCR2 Antagonists
In force
 · High confidence
In forceHigh confidence
US 10,196,402New CCR2 Receptor Antagonists and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,046,706CCR2 Receptor Antagonists and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 11,731,981CCR2 Receptor Antagonists and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,670,222New CCR2 Receptor Antagonists and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,371,282New Somatostatin receptor subtype 4 (SSTR4) agonists
In force
 · High confidence
In forceHigh confidence
US 9,789,082New Somatostatin Receptor Subtype 4 (SSTR4) Agonists
In force
 · High confidence
In forceHigh confidence
US 10,166,214Somatostatin Receptor Subtype 4 (SSTR4) Agonists
In force
 · High confidence
In forceHigh confidence
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
Also on record, not counted in the 35: 8 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 6 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited